Validation of Standard Manufacturing procedure of Kamsaharitaki avaleha prepared by two different varieties of Haritaki and their comparative effect on Tamaka Shwasa, A Double Blind Randomized Clinical Trial.

Director0 个研究点目标入组 61 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1. Patients presenting with minimum 3 to 4 classical signs and symptoms of Tamaka Shwasa.
•2. Mild persistent cases of asthma (as per WHO GINA guidelines) of duration more than 6 months.

•1.Age more than 60 years and below 18years.
•2.Mild intermittent, moderated persistent, severe persistent to severe asthma.
•3.Dyspnoea resulting from other diseases like left ventricular failure, COPD (chronic bronchitis, emphysema), upper respiratory tract obstruction, bronchiectasis, etc.
•4.Patients on regular steroidal therapy, inhalers or bronchodilators.
•5.Patients having pneumonia, tuberculosis, lung cancer, lung abscess and another such complicated conditions.
•6.Patients having diabetes, hypertension, acute and chronic renal failure etc. conditions in which urination is markedly diminished or excessive were excluded.
•7.HIV positive patients.
•8.Pregnant/lactating mothers

发起方

Director